Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-02-20 @ 3:54 PM
Study NCT ID:
NCT02463604
Status:
COMPLETED
Last Update Posted:
2018-06-25
First Post:
2015-06-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography
Sponsor:
University Hospital, Angers
Organization:
Study Overview
Official Title:
Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography
Status:
COMPLETED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PREPARE
Brief Summary:
This study evaluates the efficacy of remote ischemic preconditioning on preventing contrast medium-induced nephropathy in a population of high risk patients undergoing coronary angiography. Half of participants will receive a preconditioning procedure while the other half will receive a sham procedure.
Detailed Description:
Contrast medium-induced nephropathy has a big impact on clinical outcomes in patients suffering from renal insufficiency who undergo percutaneous coronary interventions.
Remote ischemic preconditioning is proved to protect myocardium in patients undergoing percutaneous coronary angiography.
We will evaluate the effect of remote preconditioning on renal protection.
Remote ischemic preconditioning is proved to protect myocardium in patients undergoing percutaneous coronary angiography.
We will evaluate the effect of remote preconditioning on renal protection.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: